| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
*
Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA 98195;
Infectious Disease Research Institute, Seattle, WA 98104;
Corixa Corp., Seattle, WA 98104; and
§
Immunex Corp., Seattle, WA 98101
CTL, both CD4+ and CD8+, are essential in the eradication of intracellular pathogens. Data generated using murine T cells have suggested a critical role for CD95 (Fas, Apo-1) in CD4+ T cell-induced apoptosis of target cells. In contrast, CD8+ CTL predominantly use the perforin/granzyme lytic pathway. At present little is known about the mechanism of CD4+ CTL lytic function during intracellular infection in humans. We have used human CD4+ T cells specific for purified protein derivative (PPD) of Mycobacterium tuberculosis to explore whether CD95 is the dominant cytolytic mechanism. PPD-reactive CD4+ clones efficiently lysed Ag-pulsed autologous monocytes, adherent macrophages, and EBV-transformed B cells. Addition of an antagonistic CD95 Ab had a minimal effect on cytolysis, whereas addition of MgEGTA to block perforin/granzyme resulted in complete inhibition of killing. In contrast, lysis of activated peripheral blood B cells could be partially blocked with the antagonistic CD95 Ab. Supporting these observations, monocytes, macrophages, and EBV-transformed B cells were not lysed by an agonistic CD95 Ab. Activated B cells were readily lysed by the agonistic CD95 Ab. T cell clones triggered through the TCR with anti-CD3 were capable of lysing the CD95-sensitive Jurkat T cell line in a CD95-dependent manner, but were also able to release granzymes. We conclude that human CD4+ T cells are capable of lysing PPD-pulsed targets using both perforin/granzyme and CD95 pathways. The contribution of CD95 is strictly dependent on target cell susceptibility to CD95-mediated killing.
This article has been cited by other articles:
|
|
 |
|
  J. S. Woodworth, Y. Wu, and S. M. Behar Mycobacterium tuberculosis-Specific CD8+ T Cells Require Perforin to Kill Target Cells and Provide Protection In Vivo J. Immunol., December 15, 2008; 181(12): 8595 - 8603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Andersson, A. Samarina, J. Fink, S. Rahman, and S. Grundstrom Impaired Expression of Perforin and Granulysin in CD8+ T Cells at the Site of Infection in Human Chronic Pulmonary Tuberculosis Infect. Immun., November 1, 2007; 75(11): 5210 - 5222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Zheng, L. L. Ma, G. J. Jones, M. J. Gill, A. M. Krensky, P. Kubes, and C. H. Mody Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients Blood, March 1, 2007; 109(5): 2049 - 2057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Le Clorennec, I. Youlyouz-Marfak, E. Adriaenssens, J. Coll, G. W. Bornkamm, and J. Feuillard EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-{kappa}B, STAT1, and p53 Blood, March 1, 2006; 107(5): 2070 - 2078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Carranza, E. Juarez, M. Torres, J. J. Ellner, E. Sada, and S. K. Schwander Mycobacterium tuberculosis Growth Control by Lung Macrophages and CD8 Cells from Patient Contacts Am. J. Respir. Crit. Care Med., January 15, 2006; 173(2): 238 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Schultz, B. Schuler-Thurner, V. Stroobant, L. Jenne, T. G. Berger, K. Thielemanns, P. van der Bruggen, and G. Schuler Functional Analysis of Tumor-Specific Th Cell Responses Detected in Melanoma Patients after Dendritic Cell-Based Immunotherapy J. Immunol., January 15, 2004; 172(2): 1304 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Lewinsohn, A. S. Heinzel, J. M. Gardner, L. Zhu, M. R. Alderson, and D. M. Lewinsohn Mycobacterium tuberculosis-specific CD8+ T Cells Preferentially Recognize Heavily Infected Cells Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1346 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Yanai, E. Ishii, K. Kojima, A. Hasegawa, T. Azuma, S. Hirose, N. Suga, A. Mitsudome, M. Zaitsu, Y. Ishida, et al. Essential Roles of Perforin in Antigen-Specific Cytotoxicity Mediated by Human CD4+ T Lymphocytes: Analysis Using the Combination of Hereditary Perforin-Deficient Effector Cells and Fas-Deficient Target Cells J. Immunol., February 15, 2003; 170(4): 2205 - 2213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Mahr, J. M. Boss, and L. R. Gooding The Adenovirus E3 Promoter Is Sensitive to Activation Signals in Human T Cells J. Virol., December 20, 2002; 77(2): 1112 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Lewinsohn, R. A. Lines, and D. M. Lewinsohn Human Dendritic Cells Presenting Adenovirally Expressed Antigen Elicit Mycobacterium tuberculosis-Specific CD8+ T Cells Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 843 - 848. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. D. Chan, J. Chan, and N. W. Schluger What is the Role of Nitric Oxide in Murine and Human Host Defense against Tuberculosis? . Current Knowledge Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 606 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Norris, M. Sumaroka, C. Brander, H. F. Moffett, S. L. Boswell, T. Nguyen, Y. Sykulev, B. D. Walker, and E. S. Rosenberg Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4+ T-Cell Clones J. Virol., October 15, 2001; 75(20): 9771 - 9779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Merlo, D. Saverino, C. Tenca, C. E. Grossi, S. Bruno, and E. Ciccone CD85/LIR-1/ILT2 and CD152 (Cytotoxic T Lymphocyte Antigen 4) Inhibitory Molecules Down-Regulate the Cytolytic Activity of Human CD4+ T-Cell Clones Specific for Mycobacterium tuberculosis Infect. Immun., October 1, 2001; 69(10): 6022 - 6029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Canaday, R. J. Wilkinson, Q. Li, C. V. Harding, R. F. Silver, and W. H. Boom CD4+ and CD8+ T Cells Kill Intracellular Mycobacterium tuberculosis by a Perforin and Fas/Fas Ligand-Independent Mechanism J. Immunol., September 1, 2001; 167(5): 2734 - 2742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ogawa, K. Tanaka, A. Ishii, Y. Nakamura, S. Kondo, K. Sugamura, S. Takano, M. Nakamura, and K. Nagata A Novel Serum Protein That Is Selectively Produced by Cytotoxic Lymphocytes J. Immunol., May 15, 2001; 166(10): 6404 - 6412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Wigginton and D. Kirschner A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis J. Immunol., February 1, 2001; 166(3): 1951 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Lewinsohn, L. Zhu, V. J. Madison, D. C. Dillon, S. P. Fling, S. G. Reed, K. H. Grabstein, and M. R. Alderson Classically Restricted Human CD8+ T Lymphocytes Derived from Mycobacterium tuberculosis-Infected Cells: Definition of Antigenic Specificity J. Immunol., January 1, 2001; 166(1): 439 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Chang, L. Galle, D. Maggs, D. M. Estes, and W. J. Mitchell Pathogenesis of Herpes Simplex Virus Type 1-Induced Corneal Inflammation in Perforin-Deficient Mice J. Virol., December 15, 2000; 74(24): 11832 - 11840. [Abstract] [Full Text]
|
|
|
|
|
|
S. Thoma-Uszynski, S. Stenger, and R. L. Modlin CTL-Mediated Killing of Intracellular Mycobacterium tuberculosis Is Independent of Target Cell Nuclear Apoptosis J. Immunol., November 15, 2000; 165(10): 5773 - 5779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Liang, M. J. Kashgarian, A. H. Sharpe, and M. J. Mamula Autoantibody Responses and Pathology Regulated by B7-1 and B7-2 Costimulation in MRL/lpr Lupus J. Immunol., September 15, 2000; 165(6): 3436 - 3443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, B. Detrick, Z.-X. Yu, J. Zhang, L. Chesky, and J. J. Hooks The Role of Apoptosis within the Retina of Coronavirus-Infected Mice Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3011 - 3018. [Abstract] [Full Text]
|
|
|
|
|
|
L. Bouhdoud, P. Villain, A. Merzouki, M. Arella, and C. Couture T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus (HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone, Induced by a Natural HIV Type 1 Variant Peptide J. Virol., March 1, 2000; 74(5): 2121 - 2130. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. Gagnon, F. A. Ennis, and A. L. Rothman Bystander Target Cell Lysis and Cytokine Production by Dengue Virus-Specific Human CD4+ Cytotoxic T-Lymphocyte Clones J. Virol., May 1, 1999; 73(5): 3623 - 3629. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
